Skip to main content

Table 2 OCT-A flow density [%] in patients with glaucoma undergoing Tafluprost therapy and post-surgery in different areas/segments: optic nerve area, macular area superficial retinal plexus from the inner limiting membrane to the inner plexiform layer and macular area deep retinal plexus from inner plexiform layer to outer plexiform layer. P-values were calculated via unpaired t-tests and adjusted using Sidák correction. Significant P-values are printed in bold

From: OCT angiography analysis of retinal vessel density in primary open-angle glaucoma with and without Tafluprost therapy

Flow density [%]

Tafluprost-treated eyes

Post-surgery eyes

P-value

Optic nerve area

 central

39.3 ± 11.8

32.8 ± 5.9

0.04

 superior

41.1 ± 9.4

32.1 ± 7.4

0.001

 temporal

32.1 ± 14.9

20.9 ± 5.9

<  0.0001

 inferior

42.6 ± 12.4

30.4 ± 8.9

<  0.0001

 nasal

23.8 ± 10.1

15.7 ± 4.9

0.003

Macular area, superficial retinal plexus

 central

11.7 ± 3.7

8.0 ± 2.7

0.78

 superior

28.3 ± 13.7

23.3 ± 4.8

0.21

 temporal

17.5 ± 8

14.4 ± 3.7

0.89

 inferior

26.6 ± 10.5

19.7 ± 3.2

0.03

 nasal

25.7 ± 8.7

21.3 ± 6.1

0.47

Macular area, deep retinal plexus

 central

21.1 ± 6.2

15.5 ± 5.6

0.14

 superior

39.5 ± 7.2

34.2 ± 9.3

0.22

 temporal

29.8 ± 5.4

25.5 ± 10.4

0.55

 inferior

31.1 ± 10.9

27.0 ± 9.2

0.64

 nasal

40.4 ± 7.6

35.3 ± 10.9

0.30